The European Society for Hemapheresis - short ESFH - was founded in 1984 with the aim of gathering European physicians, scientists, and allied health personnel working in the field of Hemapheresis with a vision to improve donor and patient care. The mission of ESFH is to advance knowledge in apheresis techniques through education, to consolidate and spread proven methods, and to open new paths in the collection of blood cells and treatment of diseases by apheresis.

Learn More

From the literature:

Important

Upcoming Meetings

22nd ESFH CONGRESS
which will be held as ahybrid joint meeting of the
Turkish Hematology Society, WAA and ESFH
September 14th – 17th, 2022, Istanbul, Turkey

Abstract Submission deadline extended to June 10th,2022
https://waa2022.org/abstract-submission/ or https://worldapheresis.org/

 Webinar“How to optimize blood transfusion treatment outcomes for SCD patients?”

 

Previous ESFH Congress 

ESFH 21th Congress
2021,May 26th - 27th Digital (rescheduled)

ESFH 20th Congress  2018
13th/14th June 2018 Hospital La Fe, Valencia, Spain

 

 

Characterization of buffy coat-derived granulocytes for clinical use: a...

Recently an interesting investigation was published in Vox Sanguinis concerning in vitro evaluation of buffy coat derived granulocytes for the...

Mobilization of Hematopoietic Progenitor Cells from Allogeneic Healthy...

In this paper, the group from Pamplona shows data of stem cell mobilization with filgrastim (G-CSF) in 36 healthy family donors, of which 18...

Adverse events in apheresis: An update of the WAA registry data

In this paper the authors reviewed more than 50.000 extracorporeal procedures in 7.142 patients regarding incidence and severity of apheresis...